• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Alopecia
    8 Drugs classified under this therapeutic system


    All the Therapeutic System Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Diane 35
    Bayer
    RX
    full basket chart
    Multiple ingredients
    Diane 35

    Anti-Androgen. Cyproterone 2 mg, Ethinylestradiol 35 mcg.
    COATED TABS: 21. 1 tab. dly. for 21 days,
    starting 1st day of menstrual cycle.
    See lit.
    Signs of androgenization in women:
    Pronounced forms acne, androgenat.
    alopecia, mild forms hirsutism.
    C/I Hypersens.
    Concom. use with another hormone. contraceptive.
    VT present or in history (DVT, PE)
    Arter. thrombos. present or in hist. (e.g. MI) or prodromal conditions (e.g.angina p.and TIA).
    Presence or hist. of cerebrovasc.accident
    The presence of a severe or multiple risk factor(s) for venous/ arterial thrombos. such as: diabetes mell. with vasc. sympt., severe hypertens., severe dyslipoproteinaemia
    Heredit. or acquired predisposit. for venous/ arterial thrombosis, such as activated protein C.
    (APC) resistance, antithrombin-III-defic., protein C defic., protein S defic., hyperhomocysteinaemia and antiphospholipid-antibodies (anticardiolipin-antibodies, lupus anticoagulant).
    History of migraine with focal neurology. sympt.
    Presence or hist.of severe hep. dis.e.g. active viral hepatitis and severe cirrhosis, as long as liver funct. values have not returned to normal.
    Presence or history of liver tumours (benign or malignant).
    Current or history of breast canc.
    Meningioma or history of meningioma.
    Known or suspected preg.
    Lact.

    Finasteride Teva 1 mg
    Abic
    RX
    not in the basket chart
    Finasteride Teva 1 mg

    5-α Reductase Inhibitor. Finasteride 1 mg.
    TABS: 1 mg x 30, 100.
    1 mg tablet x 1 dly. May be taken with/
    without meals.
    Effic., durat. of tmt. should contin. be
    assessed by the treat. physic. Gener., 3
    or more mths. of once dly. tmt. are
    required before evidence of benefit is
    observed. Contin. use is recom. to sustain benefit, which should be
    re-eval. period.
    Tmt. of men with male pattern hair loss
    (androgenetic alopecia) to incr. hair
    growth and prevent further hair loss.
    C/I: Hypersens. to product, not for use in
    women and child., not to be used in
    comb. with any other med. contain.
    Finasteride, Dutasteride, preg.

    Hairgain 5%
    Perrigo
    OTC
    not in the basket chart
    Hairgain 5%

    Hair Restorer. Minoxidil 5%.
    TOP. SOLN: 1,2 x 60 ml. Apply 1 ml 2 x dly
    to scalp. See lit.
    TOP. FOAM: 1 x 60 g. Apply 1 gr 2 x dly
    to scalp. See lit.
    Hair regrowth tmt in men.
    C/I: Hypersens., women.

    Minoxi 2
    Trima
    OTC
    not in the basket chart
    Minoxi 2

    Hair Restorer. Minoxidil 2%.
    METERED SPRAY: 80 ml. Apply 2 x dly.
    See lit.
    Alopecia androgen.
    C/I: Hypersens. to minoxidil.

    Minoxi 5
    Trima
    OTC
    not in the basket chart
    Minoxi 5

    Hair Restorer. Minoxidil 5%.
    METERED SPRAY: 80 ml. Apply 2 x dly.
    Alopec. androgen.
    C/I: Hypersens.

    Noxidil 5%
    Perrigo
    OTC
    not in the basket chart
    Noxidil 5%

    Hair Restorer. Minoxidil 5%.
    SOLN: 2 x 60 ml. Apply 1 ml 2 x dly on
    scalp. Max. dly dose: 2 ml.
    Alopecia androgen. in men.
    C/I: Women, hypersens.


    Other therapeutic systems under Dermatological Preparations

    CLOSE